Showing results (101-110 of 113) with videos related to
Sort By:
Pageof 12
NPJ Vaccines|August 9, 2024
Inactivated rabies-based Lassa fever virus vaccine candidate LASSARAB protects nonhuman primates from lethal diseaseGabrielle Scher, Catherine Yankowski, Drishya Kurup, et al.Journal of the National Cancer Institute|June 26, 2008
Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunityAdam E Snook, Benjamin J Stafford, Peng Li, et al.NPJ Vaccines|August 19, 2025
Immunogenicity and safety of a rabies-based highly pathogenic influenza A virus H5 vaccine in cattleNir Paran, Christoph Wirblich, Catherine Olal, et al.Journal of Virology|April 18, 2014
Small-molecule probes targeting the viral PPxY-host Nedd4 interface block egress of a broad range of RNA virusesZiying Han, Jianhong Lu, Yuliang Liu, et al.The Journal of Infectious Diseases|March 3, 2007
Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like diseasePhilip M McKenna, Martin L Koser, Kevin R Carlson, et al.NPJ Vaccines|July 23, 2021
A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19Delphine C Malherbe, Drishya Kurup, Christoph Wirblich, et al.Diagnostics (Basel, Switzerland)|November 27, 2021
A Strategy to Detect Emerging Non-Delta SARS-CoV-2 Variants with a Monoclonal Antibody Specific for the N501 Spike ResidueRama Devudu Puligedda, Fetweh H Al-Saleem, Cristoph Wirblich, et al.The Journal of Infectious Diseases|July 27, 2016
An Inactivated Rabies Virus-Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge ModelsReed F Johnson, Drishya Kurup, Katie R Hagen, et al.Journal of Virology|August 19, 2011
Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola virusesJoseph E Blaney, Christoph Wirblich, Amy B Papaneri, et al.Science Signaling|January 21, 2010
Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope proteinChristophe Préhaud, Nicolas Wolff, Elouan Terrien, et al.Pageof 12